Cardiac SurgeryNCT07083297
Study of Readmission to Intensive Care Unit After Cardiac Surgery in Heart Hospital of Assiut University : Risk Factors .Reasons and Early Out Come
An observational study of Cardiac Surgery, run by Assiut University.
Trial summary
Cardiac Surgery is any surgical procedure applied to heart and its connected vessels especially thoracic aorta; representing a treatment option for significant cardiac diseases . Read more about this study
- Who is it for?
- Ages 18 to 85 years
- Conditions the study is for
- Cardiac Surgery
- How many people
- 89 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2025to 1 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients admitted for cardic surgery
Who may be able to join
- Adult Patients aged between 18 to 85 years.
- Patients with previous heart surgery.
- Patients will be admitted in Cardiac ICU during the study duration.
Who cannot join
- Pediatric patients aged below 18 years. b. Elderly Patients aged above 85 years. c. Patient without previous heart surgery. d. Patients are for emergent reoperation. e. Patients admitted in ICU due to Chest Trauma. f. Patients refused consent.
About this study
Cardiac Surgery is any surgical procedure applied to heart and its connected vessels especially thoracic aorta; representing a treatment option for significant cardiac diseases . As cardiovascular (CVS) diseases is the first leading cause of death worldwide accounting for approximately18 million deaths annually especially in low and middle income countries , medical and surgical treatments are of importance in quality of life of cardiac patient.
Most common causes for cardiac surgery are Coranary artery disease, valvular disease as mitral stenosis or mitral regurgitation, congenital heart diseases. Currently cardiac surgery can provide an advanced treatment for cardiac arrhythmias.
Read more
In case of cardiovascular surgery, patient is admitted in Intensive Care Unit (ICU) postoperatively until being stable then discharged. In some cases the patient's state is indicating to be readmitted in ICU, a condition that's required long hospitzation, costs and so, a burden on health services and patient's family.
For controlling this phenomenon; i.e. readmission in ICU, a lot researches were conducted to clarify the leading factors and the outcome in readmitted patients. Preoperative risk factors as renal failure, arrhythmias, chronic obstructive pulmonary disease (COPD) are common noticed factors for readmission of previous heart surgery patient. Also, readmitted patients may have poor clinical outcomes as morbidity and mortality.
In this study we aim to screen for preceding risk factors and report precipitating early events occurring in readmission in ICU.
- Conditions
- Cardiac Surgery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| study group | patients admitted for cardic surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
mortality rate
mortality rate after cardic surgery
Measured: 30 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2025
- Study start1 Aug 2025 (estimated)
- Primary completion1 Aug 2026 (estimated)
- Study completion1 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiac SurgeryStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 89 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Abdullah Mohamed sayed Ali, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07083297
- Sponsor's protocol ID
- ICU after cardiac surgery
- Status last verified
- Jul 2025
- First submitted
- 16 Jul 2025
- Last updated
- 24 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Readmission to Intensive Care Unit After Cardiac Surgery in Heart Hospital of Assiut University : Risk Factors .Reasons and Early Out Come
- ClinicalTrials.gov ID
- NCT07083297
- Acronym / sponsor ID
- ICU after cardiac surgery
- Conditions
- Cardiac Surgery
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 89 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Aug 2025 (estimated)
- Primary completion
- 1 Aug 2026 (estimated)
- Study completion
- 1 Sep 2026 (estimated)
- First posted
- 24 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cardiac Surgery is any surgical procedure applied to heart and its connected vessels especially thoracic aorta; representing a treatment option for significant cardiac diseases . As cardiovascular (CVS) diseases is the first leading cause of death worldwide accounting for approximately18 million deaths annually especially in low and middle income countries , medical and surgical treatments are of importance in quality of life of cardiac patient.
Most common causes for cardiac surgery are Coranary artery disease, valvular disease as mitral stenosis or mitral regurgitation, congenital heart diseases. Currently cardiac surgery can provide an advanced treatment for cardiac arrhythmias.
In case of cardiovascular surgery, patient is admitted in Intensive Care Unit (ICU) postoperatively until being stable then discharged. In some cases the patient's state is indicating to be readmitted in ICU, a condition that's required long hospitzation, costs and so, a burden on health services and patient's family.
For controlling this phenomenon; i.e. readmission in ICU, a lot researches were conducted to clarify the leading factors and the outcome in readmitted patients. Preoperative risk factors as renal failure, arrhythmias, chronic obstructive pulmonary disease (COPD) are common noticed factors for readmission of previous heart surgery patient. Also, readmitted patients may have poor clinical outcomes as morbidity and mortality.
In this study we aim to screen for preceding risk factors and report precipitating early events occurring in readmission in ICU.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| study group | – | –patients admitted for cardic surgery |
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients admitted for cardic surgery
Key inclusion criteria (3 listed)
- Adult Patients aged between 18 to 85 years.
- Patients with previous heart surgery.
- Patients will be admitted in Cardiac ICU during the study duration.
Key exclusion criteria (1 listed)
- Pediatric patients aged below 18 years. b. Elderly Patients aged above 85 years. c. Patient without previous heart surgery. d. Patients are for emergent reoperation. e. Patients admitted in ICU due to Chest Trauma. f. Patients refused consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
mortality rate
Time frame: 30 day
mortality rate after cardic surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jul 2025.
Related trials for Cardiac Surgery
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
Recruiting
Change in Platelet Lipid Metabolism and Procoagulant Phenotype Induced by Cardiopulmonary Bypass. Impact on Postoperative Inflammatory Response and Bleeding Complications During Cardiac Surgery.
Cardiac Surgery, Cardiopulmonary Bypass
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
RecruitingObservational study
Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
Coronary Artery Disease, Left Ventricular Systolic Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiac Surgery, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
mortality rate (time frame: 30 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.